AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMPEDIMED LTD

0.005

0.000

Volume:1.09M

Turnover:5K

Market Cap:18.30M

PE:-0.42

High:0.005

Open:0.005

Low:0.005

Close:0.005

52wk High:0.055

52wk Low:0.003

Shares:3.66B

Float Shares:2.15B

Volume Ratio:0.20

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.012

EPS(LYR):-0.012

ROE:-117.92%

ROA:-35.93%

PB:2.03

PE(LYR):-0.43

Loading ...

Overview Company News Filings

ImpediMed Ltd-FDA Clearance for Sarcopenia Risk Assessment Received

THOMSON REUTERS

Sozo® Digital Health Platform Receives FDA Clearance for Sarcopenia Risk Assessment

THOMSON REUTERS

ImpediMed - Sarcopenia Capability to Launch with Sozo Software V6.3 in Fall 2026

THOMSON REUTERS

ImpediMed Ltd - Breach of ASX Listing Rule 7.16 and a Related Breach of ASX Listing Rule 3.10.3e

THOMSON REUTERS

ImpediMed Ltd - Has Undertaken a Review of Circumstances That Gave Rise to These Breaches

THOMSON REUTERS

Fiona Bones Bought 911% More Shares In ImpediMed

Simply Wall St.

ImpediMed Ltd-Oversubscribed Share Purchase Plan Successfully Completed

THOMSON REUTERS

ImpediMed Ltd-Share Purchase Plan Close Date

THOMSON REUTERS

ImpediMed Ltd-CEO Business Update

THOMSON REUTERS

ImpediMed Ltd-Share Purchase Plan Opens

THOMSON REUTERS

BUZZ-Australia's ImpediMed falls to record low on discounted placement

BRIEF-Impedimed Receives Commitments To Raise A$13.2 Million

ImpediMed Ltd - Receives Firm Commitments to Raise a$13.2 Mln at a$0.010 per Share

THOMSON REUTERS

BRIEF-Impedimed Logs Qtrly Revenue A$3.5 Mln

BRIEF-Impedimed Requests Trading Halt

ImpediMed Ltd - Q3 FY26 Revenue a$3.5 Mln

THOMSON REUTERS

ImpediMed Appoints Erik Anderson as Chief Executive Officer

THOMSON REUTERS

BRIEF-Impedimed Appoints Erik Anderson As Managing Director And CEO

ImpediMed Ltd - Appoints Erik Anderson as Managing Director and CEO

THOMSON REUTERS

BRIEF-Impedimed HY Loss Before Tax A$12.3 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IPD.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IPD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IPD.AU\",,,,,undefined,":{"symbol":"IPD.AU","market":"AU","secType":"STK","nameCN":"IMPEDIMED LTD","latestPrice":0.005,"timestamp":1787292720000,"preClose":0.005,"halted":0,"volume":1087078,"delay":0,"changeRate":0,"nameEN":"IMPEDIMED LTD","floatShares":2153356835,"shares":3659805353,"eps":-0.012038,"marketStatus":"Market Closed","change":0,"latestTime":"08-21 16:12:00 AEST","open":0.005,"high":0.005,"low":0.005,"amount":5435,"amplitude":0,"askPrice":0.006,"askSize":9664097,"bidPrice":0.005,"bidSize":36609981,"shortable":3,"etf":0,"ttmEps":-0.012038,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.005,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.2038413174563143,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IPD.AU","preClose":0.005,"auctionPrice":0.005,"auctionVolume":2060000,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600826}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IPD.AU\",,,,,undefined,":{"symbol":"IPD.AU","floatShares":2153356835,"roa":"-35.93%","roe":"-117.92%","lyrEps":-0.011508,"volumeRatio":0.2038413174563143,"shares":3659805353,"dividePrice":0,"high":0.005,"amplitude":0,"preClose":0.005,"low":0.005,"week52Low":0.003,"pbRate":"2.03","psRate":"1.29","week52High":0.055,"institutionHeld":0,"latestPrice":0.005,"committee":0.582311,"eps":-0.012038,"divideRate":0,"volume":1087078,"delay":0,"ttmEps":-0.012038,"open":0.005,"prevYearClose":0.034,"prevWeekClose":0.006,"prevMonthClose":0.004,"prevQuarterClose":0.005,"fiveDayClose":0.006,"twentyDayClose":0.004,"sixtyDayClose":0.006,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPD.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-28","symbol":"IPD.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785196800000,"name":null,"time":"","dateTimestamp":1785160800000,"actualEps":null},{"date":"2026-01-28","symbol":"IPD.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769554800000,"name":null,"time":"","dateTimestamp":1769518800000,"actualEps":null},{"date":"2025-10-29","symbol":"IPD.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761692400000,"name":null,"time":"","dateTimestamp":1761656400000,"actualEps":null},{"date":"2025-07-31","symbol":"IPD.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753920000000,"name":null,"time":"","dateTimestamp":1753884000000,"actualEps":null},{"date":"2025-04-30","symbol":"IPD.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1745971200000,"name":null,"time":"","dateTimestamp":1745935200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPD.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660418651","title":"ImpediMed Ltd-FDA Clearance for Sarcopenia Risk Assessment Received","url":"https://stock-news.laohu8.com/highlight/detail?id=2660418651","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660418651?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:51","pubTimestamp":1787097061,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUE89SX0N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IPD.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660496994","title":"Sozo® Digital Health Platform Receives FDA Clearance for Sarcopenia Risk Assessment","url":"https://stock-news.laohu8.com/highlight/detail?id=2660496994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660496994?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:15","pubTimestamp":1787069741,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUA7ZTJ3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IPD.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660496942","title":"ImpediMed - Sarcopenia Capability to Launch with Sozo Software V6.3 in Fall 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660496942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660496942?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:15","pubTimestamp":1787069741,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUA7ZTJ3Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7509","IPD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659373851","title":"ImpediMed Ltd - Breach of ASX Listing Rule 7.16 and a Related Breach of ASX Listing Rule 3.10.3e","url":"https://stock-news.laohu8.com/highlight/detail?id=2659373851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659373851?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:46","pubTimestamp":1786610762,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN4491UH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","IPD.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659137386","title":"ImpediMed Ltd - Has Undertaken a Review of Circumstances That Gave Rise to These Breaches","url":"https://stock-news.laohu8.com/highlight/detail?id=2659137386","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659137386?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:46","pubTimestamp":1786610762,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN4491UH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7509","IPD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645630091","title":"Fiona Bones Bought 911% More Shares In ImpediMed","url":"https://stock-news.laohu8.com/highlight/detail?id=2645630091","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645630091?lang=en_us&edition=fundamental","pubTime":"2026-06-21 06:30","pubTimestamp":1781994623,"startTime":"0","endTime":"0","summary":"Investors who take an interest in ImpediMed Limited ( ASX:IPD ) should definitely note that the Independent...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ipd/impedimed-shares/news/fiona-bones-bought-911-more-shares-in-impedimed","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ipd/impedimed-shares/news/fiona-bones-bought-911-more-shares-in-impedimed","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","IPD.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642413577","title":"ImpediMed Ltd-Oversubscribed Share Purchase Plan Successfully Completed","url":"https://stock-news.laohu8.com/highlight/detail?id=2642413577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642413577?lang=en_us&edition=fundamental","pubTime":"2026-06-10 07:05","pubTimestamp":1781046322,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUE6WVV09:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","IPD.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640996368","title":"ImpediMed Ltd-Share Purchase Plan Close Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2640996368","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640996368?lang=en_us&edition=fundamental","pubTime":"2026-06-02 09:42","pubTimestamp":1780364577,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUEC2HR5Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7007","IPD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640996357","title":"ImpediMed Ltd-CEO Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2640996357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640996357?lang=en_us&edition=fundamental","pubTime":"2026-06-02 09:42","pubTimestamp":1780364542,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUERFD9S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7509","IPD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634551822","title":"ImpediMed Ltd-Share Purchase Plan Opens","url":"https://stock-news.laohu8.com/highlight/detail?id=2634551822","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634551822?lang=en_us&edition=fundamental","pubTime":"2026-05-12 06:22","pubTimestamp":1778538131,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUE8DBWDB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7007","IPD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632982469","title":"BUZZ-Australia's ImpediMed falls to record low on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2632982469","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632982469?lang=en_us&edition=fundamental","pubTime":"2026-05-04 10:55","pubTimestamp":1777863356,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's ImpediMed falls to record low on discounted placement** Shares of ImpediMed IPD.AX fall as much as 50% to a record low of A$0.007** Medical technology firm receives firm commitments to raise A$13.2 million ** Issue price of A$0.010 per share represents a discount of nearly 29% to the stock's last close** Proceeds will be used for partial prepayment of the SWK Growth Capital Facility, and others** About 28.2 million shares change hands, 9.4 times the 30-day avg ** Down 73.5% YTD, including the session's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL6N41H02E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7509","IPD.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632981434","title":"BRIEF-Impedimed Receives Commitments To Raise A$13.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2632981434","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632981434?lang=en_us&edition=fundamental","pubTime":"2026-05-04 09:01","pubTimestamp":1777856483,"startTime":"0","endTime":"0","summary":"BRIEF-Impedimed Receives Commitments To Raise A$13.2 MillionMay 4 (Reuters) - ImpediMed Ltd IPD.AX:RECEIVES FIRM COMMITMENTS TO RAISE A$13.2 MILLION AT A$0.010 PER SHAREFurther company coverage: IPD.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41E0LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7509","BK7007","IPD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632981185","title":"ImpediMed Ltd - Receives Firm Commitments to Raise a$13.2 Mln at a$0.010 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2632981185","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632981185?lang=en_us&edition=fundamental","pubTime":"2026-05-04 08:55","pubTimestamp":1777856143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41E0LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IPD.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631569574","title":"BRIEF-Impedimed Logs Qtrly Revenue A$3.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631569574","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631569574?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:42","pubTimestamp":1777513333,"startTime":"0","endTime":"0","summary":"BRIEF-Impedimed Logs Qtrly Revenue A$3.5 MlnApril 30 (Reuters) - ImpediMed Ltd IPD.AX:Q3 FY26 REVENUE A$3.5 MILLIONFurther company coverage: IPD.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C1TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPD.AU","BK7509","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631716571","title":"BRIEF-Impedimed Requests Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2631716571","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631716571?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:31","pubTimestamp":1777512689,"startTime":"0","endTime":"0","summary":"BRIEF-Impedimed Requests Trading Halt April 30 (Reuters) - ImpediMed Ltd IPD.AX:REQUESTS TRADING HALT FOR POTENTIAL MATERIAL CAPITAL RAISINGFurther company coverage: IPD.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C1RE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7509","BK7007","IPD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631520866","title":"ImpediMed Ltd - Q3 FY26 Revenue a$3.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631520866","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631520866?lang=en_us&edition=fundamental","pubTime":"2026-04-30 06:20","pubTimestamp":1777501236,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41C1TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IPD.AU","BK7007","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625663219","title":"ImpediMed Appoints Erik Anderson as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2625663219","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625663219?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:29","pubTimestamp":1775593777,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nTUA1FVLZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IPD.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625986868","title":"BRIEF-Impedimed Appoints Erik Anderson As Managing Director And CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2625986868","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625986868?lang=en_us&edition=fundamental","pubTime":"2026-04-07 10:29","pubTimestamp":1775528994,"startTime":"0","endTime":"0","summary":"BRIEF-Impedimed Appoints Erik Anderson As Managing Director And CEOApril 7 (Reuters) - ImpediMed Ltd IPD.AX:APPOINTMENT OF CEO/MANAGING DIRECTORAPPOINTS ERIK ANDERSON AS MANAGING DIRECTOR AND CEOFurther company coverage: IPD.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nTUE5DHHCT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPD.AU","BK7509","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625076596","title":"ImpediMed Ltd - Appoints Erik Anderson as Managing Director and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2625076596","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625076596?lang=en_us&edition=fundamental","pubTime":"2026-04-07 06:31","pubTimestamp":1775514691,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nTUE5DHHCT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IPD.AU","BK7007","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614069923","title":"BRIEF-Impedimed HY  Loss Before Tax A$12.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614069923","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614069923?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:32","pubTimestamp":1772069520,"startTime":"0","endTime":"0","summary":"BRIEF-Impedimed HY  Loss Before Tax A$12.3 MillionFeb 26 (Reuters) - ImpediMed Ltd IPD.AX:HY  LOSS BEFORE TAX A$12.3 MILLIONHY  TOTAL REVENUE A$7.5 MILLIONFurther company coverage: IPD.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nFWN3ZL1DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPD.AU","BK7509","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}